Annual CFI
-$5.67 M
-$33.69 M-120.21%
31 December 2023
Summary:
Rhythm Pharmaceuticals annual cash flow from investing activities is currently -$5.67 million, with the most recent change of -$33.69 million (-120.21%) on 31 December 2023. During the last 3 years, it has fallen by -$164.20 million (-103.57%). RYTM annual CFI is now -103.57% below its all-time high of $158.53 million, reached on 31 December 2020.RYTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$90.82 M
-$82.26 M-960.71%
30 September 2024
Summary:
Rhythm Pharmaceuticals quarterly cash flow from investing activities is currently -$90.82 million, with the most recent change of -$82.26 million (-960.71%) on 30 September 2024. Over the past year, it has increased by +$4.14 million (+4.36%). RYTM quarterly CFI is now -225.23% below its all-time high of $72.52 million, reached on 31 March 2022.RYTM Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$46.69 M
+$4.14 M+8.15%
30 September 2024
Summary:
Rhythm Pharmaceuticals TTM cash flow from investing activities is currently -$46.69 million, with the most recent change of +$4.14 million (+8.15%) on 30 September 2024. Over the past year, it has increased by +$22.39 million (+32.41%). RYTM TTM CFI is now -126.15% below its all-time high of $178.53 million, reached on 30 June 2022.RYTM TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RYTM Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -120.2% | +4.4% | +32.4% |
| 3 y3 years | -103.6% | -244.7% | -520.9% |
| 5 y5 years | +93.5% | -319.0% | -137.8% |
RYTM Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -103.6% | +90.9% | -225.2% | +4.4% | -126.2% | +32.4% |
| 5 y | 5 years | -103.6% | +93.5% | -225.2% | +37.7% | -126.2% | +32.4% |
| alltime | all time | -103.6% | +94.8% | -225.2% | +37.7% | -126.2% | +77.9% |
Rhythm Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$90.82 M(+960.7%) | -$46.69 M(-8.1%) |
| June 2024 | - | -$8.56 M(-128.5%) | -$50.83 M(-958.5%) |
| Mar 2024 | - | $30.05 M(+32.7%) | $5.92 M(-204.5%) |
| Dec 2023 | -$5.67 M(-120.2%) | $22.64 M(-123.8%) | -$5.67 M(-91.8%) |
| Sept 2023 | - | -$94.96 M(-297.0%) | -$69.08 M(+400.0%) |
| June 2023 | - | $48.19 M(+161.0%) | -$13.82 M(-46.9%) |
| Mar 2023 | - | $18.46 M(-145.3%) | -$26.03 M(-192.9%) |
| Dec 2022 | $28.03 M(-145.1%) | -$40.77 M(+2.7%) | $28.03 M(-63.1%) |
| Sept 2022 | - | -$39.70 M(-210.3%) | $76.05 M(-57.4%) |
| June 2022 | - | $35.98 M(-50.4%) | $178.53 M(+14.4%) |
| Mar 2022 | - | $72.52 M(+900.6%) | $156.07 M(-351.1%) |
| Dec 2021 | -$62.16 M(-139.2%) | $7.25 M(-88.5%) | -$62.16 M(+726.6%) |
| Sept 2021 | - | $62.78 M(+364.2%) | -$7.52 M(-78.8%) |
| June 2021 | - | $13.53 M(-109.3%) | -$35.39 M(+120.4%) |
| Mar 2021 | - | -$145.71 M(-335.4%) | -$16.05 M(-110.1%) |
| Dec 2020 | $158.53 M | $61.89 M(+77.3%) | $158.53 M(-473.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $34.91 M(+6.2%) | -$42.48 M(+18.3%) |
| June 2020 | - | $32.86 M(+13.8%) | -$35.92 M(+58.7%) |
| Mar 2020 | - | $28.87 M(-120.8%) | -$22.64 M(-19.1%) |
| Dec 2019 | -$27.97 M(-67.9%) | -$139.13 M(-435.5%) | -$27.97 M(-122.7%) |
| Sept 2019 | - | $41.47 M(-10.1%) | $123.43 M(-326.5%) |
| June 2019 | - | $46.15 M(+96.0%) | -$54.51 M(-35.3%) |
| Mar 2019 | - | $23.54 M(+91.8%) | -$84.21 M(-3.4%) |
| Dec 2018 | -$87.15 M(-20.8%) | $12.28 M(-109.0%) | -$87.15 M(-58.7%) |
| Sept 2018 | - | -$136.47 M(-930.2%) | -$210.87 M(+210.3%) |
| June 2018 | - | $16.44 M(-20.2%) | -$67.96 M(-16.5%) |
| Mar 2018 | - | $20.61 M(-118.5%) | -$81.42 M(-26.0%) |
| Dec 2017 | -$110.04 M(+2053.5%) | -$111.45 M(-1829.8%) | -$110.04 M(-7921.2%) |
| Sept 2017 | - | $6.44 M(+116.0%) | $1.41 M(-127.9%) |
| June 2017 | - | $2.98 M(-137.2%) | -$5.04 M(-37.2%) |
| Mar 2017 | - | -$8.02 M | -$8.02 M |
| Dec 2016 | -$5.11 M(>+9900.0%) | - | - |
| Dec 2015 | -$17.00 K | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual CFI year-on-year change?
- What is Rhythm Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly CFI year-on-year change?
- What is Rhythm Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM CFI year-on-year change?
What is Rhythm Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of RYTM is -$5.67 M
What is the all time high annual CFI for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual cash flow from investing activities is $158.53 M
What is Rhythm Pharmaceuticals annual CFI year-on-year change?
Over the past year, RYTM annual cash flow from investing activities has changed by -$33.69 M (-120.21%)
What is Rhythm Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of RYTM is -$90.82 M
What is the all time high quarterly CFI for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly cash flow from investing activities is $72.52 M
What is Rhythm Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, RYTM quarterly cash flow from investing activities has changed by +$4.14 M (+4.36%)
What is Rhythm Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of RYTM is -$46.69 M
What is the all time high TTM CFI for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM cash flow from investing activities is $178.53 M
What is Rhythm Pharmaceuticals TTM CFI year-on-year change?
Over the past year, RYTM TTM cash flow from investing activities has changed by +$22.39 M (+32.41%)